Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.470
-0.180 (-4.93%)
Aug 20, 2026, 10:07 AM EDT - Market open
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $380.92 million as of August 20, 2026. Its market cap has increased by 15.75% in one year.
Market Cap
380.92M
Enterprise Value
121.97M
1-Year Change
15.75%
Ranking
Category
Stock Price
$3.47
ChartMarket Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $380.92M, an increase of 299.70%. That is a compound annual growth rate of 12.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 366.60M | -3.50% |
| Dec 31, 2025 | 379.90M | -66.84% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
| Feb 18, 2015 | 95.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 399.07M |
| EyePoint | 397.44M |
| Scribe Therapeutics | 396.15M |
| Capricor Therapeutics | 389.53M |
| Upstream Bio | 388.33M |
| Palisade Bio | 382.52M |
| Enanta Pharmaceuticals | 377.17M |
| vTv Therapeutics | 370.26M |